Sarmentosin alleviates doxorubicin-induced cardiotoxicity and ferroptosis via the p62-Keap1-Nrf2 pathway
Doxorubicin (Dox) is extensively used as an antitumor agent, but its severe cardiotoxicity significantly limits its clinical use. Current treatments for Dox-induced cardiotoxicity are inadequate, necessitating alternative solutions. This study evaluated the effects of sarmentosin, a compound from Se...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis Group
2024-12-01
|
| coleção: | Redox Report |
| Assuntos: | |
| Acesso em linha: | https://www.tandfonline.com/doi/10.1080/13510002.2024.2392329 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|